克鲁佩尔样因子2是糖尿病病中的内保护性转录因子
Lulin Min1,2, Fang Zhong2, Leyi Gu1
1Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
American journal of physiology. Cell physiology
|July 9, 2024
概括
克鲁佩尔样因子2 (KLF2) 通过减少炎症和损伤,防止糖尿病病 (DKD). 较低的KLF2表达加剧了DKD,突出了其作为心脏脏保护治疗点的潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病病 (DKD) 涉及质内皮细胞 (GEC) 功能障碍.
- 克鲁佩尔样因子2 (KLF2),一种剪切压力诱导的转录因子,在DKD病变发生过程中至关重要.
- 糖尿病中的KLF2表达受剪切应激和炎症性细胞因子的调节.
研究的目的:
- 研究KLF2在糖尿病病 (DKD) 中的作用.
- 探索KLF2的脏保护和内脏保护机制.
- 评估KLF2激活剂作为潜在的治疗药物,用于心脏脏保护.
主要方法:
- 在DKD模型和人体样本中分析KLF2表达.
- 通过高葡萄糖,炎症性细胞因子 (TNF-α) 和剪切应激来研究KLF2调节.
- 评估KLF2表达对淋巴细胞损伤和白膜尿的影响.
主要成果:
- 在渐进的DKD和高血压脏病中,KLF2的表达减少.
- 降低KLF2与糖尿病和单侧腎切除术后的淋巴细胞损伤和白膜尿有关.
- KLF2通过抑制炎症,血栓激活和血管生成来赋予内膜保护.
结论:
- KLF2在DKD中起着关键的保护作用.
- 减少KLF2表达会加剧糖尿病患者的损伤.
- KLF2激活剂代表了糖尿病患者心保护的潜在新疗法策略.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
387
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
550
相关概念视频
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
